Four-Pronged attack on tough childhood cancer
NCT ID NCT05754684
Summary
This study is testing a combination of four different immune-based treatments to see if they can help control neuroblastoma in children when the cancer has returned or not responded to standard therapies. The treatment involves donor immune cells, a targeted antibody, immune-boosting proteins, and a repurposed pill. The goal is to see if this combination can shrink tumors and help children live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA RECURRENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hong Kong Children's Hospital
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.